Show simple item record

dc.contributor.authorFrezza, AM
dc.contributor.authorLee, ATJ
dc.contributor.authorNizri, E
dc.contributor.authorSbaraglia, M
dc.contributor.authorJones, RL
dc.contributor.authorGronchi, A
dc.contributor.authorDei Tos, AP
dc.contributor.authorCasali, PG
dc.coverage.spatialEngland
dc.date.accessioned2022-09-13T08:57:22Z
dc.date.available2022-09-13T08:57:22Z
dc.date.issued2018-05-01
dc.identifierUNSP e000390
dc.identifierS2059-7029(20)32309-7
dc.identifier.citationESMO Open, 2018, 3 (4), pp. e000390 -
dc.identifier.issn2059-7029
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5443
dc.identifier.eissn2059-7029
dc.identifier.eissn2059-7029
dc.identifier.doi10.1136/esmoopen-2018-000390
dc.description.abstractThe 7th edition of the 'ESMO Sarcoma and GIST Symposium' was held in Milan in February 2018. For the first time, the Symposium brought together representatives from the European Reference Network on rare adult solid cancer (EURACAN) joined by sarcoma experts from the USA, Japan and patient advocacy groups, to share insights and discuss future directions in this rare condition. This commentary will summarise the highlights in soft tissue sarcomas.
dc.formatElectronic-eCollection
dc.format.extente000390 -
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofESMO Open
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectepigenetics
dc.subjecteuracan
dc.subjectimmunotherapy
dc.subjectmassive parallel sequencing
dc.subjectsoft tissue sarcoma
dc.title2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.
dc.typeJournal Article
dcterms.dateAccepted2018-05-11
dc.date.updated2022-09-13T08:56:30Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1136/esmoopen-2018-000390
rioxxterms.licenseref.startdate2018-05-01
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30018812
pubs.issue4
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.)
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1136/esmoopen-2018-000390
pubs.volume3
dc.contributor.icrauthorLee, Alexander
icr.provenanceDeposited by Mr Arek Surman on 2022-09-13. Deposit type is initial. No. of files: 1. Files: 2018 ESMO Sarcoma and GIST Symposium take-home messages in soft tissue sarcoma.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/